Patrick Daly

DocwireNews

A recent randomized controlled trial examined if the addition of electrical posterior box isolation (POBI) to circumferential pulmonary vein isolation (CPVI) could improve outcomes of redo ablations in patients with reconnected pulmonary veins (PVs). The researchers, led by Daehoon Kim, MD, reported that CPVI with POBI, compared to CPVI alone, &ldquo;did not improve rhythm outcomes or influence overall safety,&rdquo; and actually had a longer ablation time.The study, published in JACC Clinical Electrophysiology, randomized 150 prospective patients with PV reconnection who were undergoing redo procedures to either a CPVI with POBI group (n = 75) or a CPVI-alone group (n = 75). The primary endpoint of the trial was atrial fibrillation recurrence after one procedure, while secondary endpoints included recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs.The results showed that the rate of recurrence was not significantly different between the two treatment groups (30.7% vs. 30.7%; p = 0.828) after a median follow-up of 17 months. The authors also noted that, among the 46 patients with clinical recurrence, recurrences presenting as atrial tachycardia (8.7% vs. 30.4%; p = 0.137) and cardioversion rates (21.7% vs. 47.8%; p = 0.122) were not significantly different between the groups. The rate of major complications was similar between the groups (1.3% vs. 5.3%; p = 0.363); however, the total ablation time was significantly longer in the combination intervention group (median = 1,084 [interquartile range (IQR): 704&ndash;1,664] vs. 1,595 [IQR: 1,244&ndash;2,302] seconds; p &lt; 0.001).Ultimately, Dr. Kim and colleagues deemed that the addition of POBI appeared to be more of a detriment than an advantage in patients with reconnected PVs undergoing redo ablations for atrial fibrillation.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Repeat Circumferential Pulmonary Vein Isolations With or Without Posterior Box Isolation

Atrial Fibrillation

A recent randomized controlled trial examined if the addition of electrical posterior box isolation (POBI) to circumferential pulmonary vein isolation (CPVI) could improve ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe